Found: 18
Select item for more details and to access through your institution.
Two Phase 1, Open‐Label, Mass Balance Studies to Determine the Pharmacokinetics of <sup>14</sup>C‐Labeled Isavuconazonium Sulfate in Healthy Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 207, doi. 10.1002/cpdd.376
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 1, p. 86, doi. 10.1002/cpdd.283
- By:
- Publication type:
- Article
Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 1, p. 54, doi. 10.1002/cpdd.281
- By:
- Publication type:
- Article
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 1, p. 66, doi. 10.1002/cpdd.280
- By:
- Publication type:
- Article
Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 1, p. 93, doi. 10.1002/cpdd.282
- By:
- Publication type:
- Article
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 1, p. 76, doi. 10.1002/cpdd.284
- By:
- Publication type:
- Article
Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 1, p. 44, doi. 10.1002/cpdd.285
- By:
- Publication type:
- Article
Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open‐label, phase 3, dose‐titration study.
- Published in:
- Neurourology & Urodynamics, 2021, v. 40, n. 6, p. 1490, doi. 10.1002/nau.24657
- By:
- Publication type:
- Article
Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat, a non-purine selective inhibitor of xanthine oxidase.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 1, p. 57, doi. 10.1111/j.1365-2125.2010.03667.x
- By:
- Publication type:
- Article
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 1981, doi. 10.1093/cid/ciy827
- By:
- Publication type:
- Article
A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 1, p. 53, doi. 10.1080/14397595.2020.1733214
- By:
- Publication type:
- Article
Isavuconazole for treatment of rare invasive fungal diseases.
- Published in:
- Mycoses, 2018, v. 61, n. 8, p. 518, doi. 10.1111/myc.12778
- By:
- Publication type:
- Article
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
- Published in:
- Mycoses, 2018, v. 61, n. 7, p. 485, doi. 10.1111/myc.12777
- By:
- Publication type:
- Article
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
- Published in:
- Mycoses, 2018, v. 61, n. 7, p. 420, doi. 10.1111/myc.12769
- By:
- Publication type:
- Article
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. N.PAG, doi. 10.1186/s13075-020-02336-3
- By:
- Publication type:
- Article
Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 9, p. 673, doi. 10.1177/1756283X17726018
- By:
- Publication type:
- Article
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article